Method of treating TRX mediated diseased

Details for Australian Patent Application No. 2003219803 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Richon, Victoria M; Marks, Paul A; Rifkind, Richard A; Butler, Lisa M

Agent Cullen & Co

Pub. Number AU-B-2003219803

PCT Number PCT/US03/04924

PCT Pub. Number WO2003/070188

Priority 60/357,383 15.02.02 US

Filing date 14 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 28 July 2005

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,383 15.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219803

28 July 2005 Application Accepted

  Published as AU-B-2003219803

25 August 2005 Corrigenda

  Applications Accepted - Name Index Under the name Sloan-Kettering Institute for Cancer Research, Application No. 2003219803, under INID (54) correct the title to read Method of treating TRX mediated diseases.

1 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219804-Removable closure assembly for a water treatment system

2003219802-VISUAL DISPLAY SYSTEM AND METHOD FOR DISPLAYING FARFOCUSED IMAGES IN A SIMULATOR UTILIZING A HOLOGRAPHIC COLLIMATOR